Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC

(RARE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Sector news Bio Therapeutic Drugs
12:51aGlobal chemical firms urged to source responsibly after lethal China blast - ..
RE
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
05/13REGENERON PHARMACEUTICALS : Says FDA Approves Eylea Injection for All Diabetic R..
DJ
05/10PATRICK THOMAS : Biotech Industry Woos Talent With Top Pay -- WSJ
DJ
05/09PATRICK THOMAS : Biotech Is Place to Be for Top Salaries
DJ
05/08GLOBAL MARKETS LIVE : Siemens, Airbus, Nestlé, Tesla…
05/08GILEAD SCIENCES : Goldfinch To Work on Therapies for Kidney Disease
DJ
05/07GLOBAL MARKETS LIVE : Alstom, Iliad, EuropaCorp, ArcelorMittal, Airbus, Anadarko..
05/07EU Approves Sanofi and Regeneron's Dupixent for Severe Asthma
DJ
05/07REGENERON PHARMACEUTICALS : Expense Growth Weighs on Operating Income
DJ
05/02GILEAD SCIENCES : Correction to Gilead Sciences Article
DJ
05/02GILEAD SCIENCES : Reports 28% Increase in Net Income
DJ
05/02GILEAD SCIENCES : Reports Q1 Results Above Wall Street Targets
DJ
05/02BIOGEN : Medical Organization Says Biogen-Supported Study of Experimental Drug S..
DJ
05/02GLOBAL MARKETS LIVE : Boeing, Apple, Fiat Chrysler, Bayer…
04/30PATRICK THOMAS : Gilead Sciences CFO Robin Washington to Retire
DJ
04/30ERIC SCHMIDT : Former Google executives Eric Schmidt, Diane Greene to leave boar..
RE
04/30Former Google execs Eric Schmidt, Diane Greene to leave board
RE
04/26FDA Approves Expanded Label for Praluent
DJ
04/26Regeneron, Sanofi Skin Cancer Drug Gets Warm Reception from European Regulato..
DJ
04/26Sanofi Shares Rise on Strong 1Q -- Update
DJ
04/25GILEAD SCIENCES : Phase 3 Selonsertib Study Misses Primary Endpoint
DJ
04/24S&P 500 closes at record high, even as EPS growth stagnates
RE
04/24EXACT SCIENCES : Older workers helped fuel recent U.S. growth. Can it last?
RE
04/16GILEAD SCIENCES : Insitro to Collaborate on Nonalcoholic Steatohepatitis
DJ
04/15PATRICK THOMAS : Novartis Files Application for Macular Degeneration Treatment
DJ
04/12GILEAD SCIENCES : Novo Nordisk Plan NASH Collaboration
DJ
04/08GSK wins U.S. nod for two-drug HIV combination
RE
04/08Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance
DJ
04/05GILEAD SCIENCES : Submits Supplemental NDA for Descovy for HIV Pre-Exposure Prop..
DJ
03/29Galapagos Shares Rise After Successful Rheumatoid Arthritis Drug Study
DJ
03/26JOHNSON & JOHNSON : J&J Unit Seeks FDA OK of Darzalex Combination in Multiple My..
DJ
03/11Regeneron Says FDA Approves Dupixent for Atopic Dermatitis in Adolescents
DJ
03/08Regeneron, Sanofi Get FDA Priority Review for Dupixent
DJ
03/07SHANGHAI RAAS BLOOD PRODUCTS : Spain's Grifols, China's Shanghai RAAS form strat..
RE
03/06GILEAD SCIENCES : Says Once-Daily HIV Regimen Shows Promise in Treating Teens an..
DJ
03/05FDA Approves Controversial Drug for Depression -- Update
DJ
03/05GILEAD SCIENCES : Dr. Alessandro Riva Leaving Gilead Sciences for CEO Post at Gl..
DJ
03/01MAXCYTE : Partners With Gilead to Develop CAR-T Therapy
DJ
02/25Amgen Says Delaware Jury Upholds Co's Patents On Repatha
DJ
02/25Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug
RE
02/20GLOBAL MARKETS LIVE : Nissan, Lockheed Martin, UBS, Sainsbury...
02/12MARKET SNAPSHOT: Stocks Close At 2019 High On Tentative Deal To Avert Governm..
DJ
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/06REGENERON PHARMACEUTICALS : 4Q Profit Rises
DJ
02/05U.S. jury orders Takeda to pay Bayer $155 million over haemophilia drug
RE
02/05Merck KGaA, GSK Enter Immuno-Oncology Deal Worth Up to $4.23 Billion -- Updat..
DJ
02/04GILEAD SCIENCES : Raises Dividend by 6 Cents a Share
DJ
02/04GILEAD SCIENCES : Struggling to Revamp Sales, Projects Another Annual Sales Decl..
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ULTRAGENYX PHARMACEUTICAL